Ardelyx (ARDX) Other financing activities (2014 - 2026)
Ardelyx's (ARDX) quarterly Other financing activities came in at $5.4 million in Q1 2026, up 267.21% YoY from $1.5 million in Q1 2025, and up 202.99% on a QoQ basis from -$5.3 million in Q4 2025.
Ardelyx (ARDX) Other financing activities (2014 - 2026) Analysis & Trends
Ardelyx (ARDX) has 13 years of Other financing activities data on file, last reported at $5.4 million in Q1 2026.
- Quarterly Other financing activities rose 267.21% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 327.72% YoY) and the FY2023 annual result came in at $5.0 million, up 2375.25% from the prior year.
- Other financing activities improved to $5.4 million in Q1 2026, from -$5.3 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $9.5 million in Q3 2022 to a low of -$9.4 million in Q4 2022.
- A 5-year average of $665250.0 and a median of $1.2 million in 2025 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 1510.5% in 2024, down 290.97% in 2024.
- Tracing ARDX's Other financing activities over 5 years: stood at -$9.4 million in 2022, then surged by 142.02% to $3.9 million in 2023, then sank by 290.97% to -$7.5 million in 2024, then climbed by 29.79% to -$5.3 million in 2025, then surged by 202.99% to $5.4 million in 2026.
- The last three Other financing activities figures came in at $5.4 million (Q1 2026), -$5.3 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.68 Mn |
| Jun 30, 2026 | 1.68 Mn |
| Mar 31, 2026 | 5.44 Mn |
| Mar 31, 2026 | 5.44 Mn |
| Dec 31, 2025 | -5.28 Mn |
| Dec 31, 2025 | -5.28 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Jun 30, 2025 | 988,000.00 |
| Jun 30, 2025 | 988,000.00 |
| Mar 31, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | -7.53 Mn |
| Dec 31, 2024 | -7.53 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 3.22 Mn |
| Mar 31, 2024 | 3.22 Mn |